ZTS:NYSEZoetis Inc. Analysis
Data as of 2026-08-30 - not real-time
$77.34
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zoetis Inc. is priced at $77.34 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has gained 1.0%. Momentum indicators put RSI at 53.3 (neutral) with MACD reading bullish. Price has been bracketed by support at $71.00 and resistance at $80.17.
Valuation screens as undervalued: a P/E of 12.6 sits below the sector average of 30.5. The average analyst target implies 24.1% above today's level. The 2.83% dividend yield looks covered by current payout levels.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 37.8%, a beta of 0.58 and a maximum drawdown of 54.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.
Valuation screens as undervalued: a P/E of 12.6 sits below the sector average of 30.5. The average analyst target implies 24.1% above today's level. The 2.83% dividend yield looks covered by current payout levels.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 37.8%, a beta of 0.58 and a maximum drawdown of 54.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.
Top Market Events
Animal health company Zoetis NYSE:ZTS fell short of the market’s revenue expectations in Q2 CY2026, with sales flat...The timing of Zoetis Inc.’s NYSE:ZTS latest regulatory win is particularly relevant for shareholders. Just one week...Despite a challenging US market and increased competition, Zoetis leverages its diversified portfolio and disciplined...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 104.14
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 12.6 versus sector average of 30.5
- Trading below the 200-day average of 104.14
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 12.6 versus sector average of 30.5
- Analyst targets imply +24.1% versus the current price
- Profit margin of 27.7% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth-0.20%
Profit Margin27.68%
P/E Ratio12.6
ROE64.91%
ROA15.35%
Debt/Equity294.00
Op. Cash Flow$2.8B
Free Cash Flow$2.0B
Industry P/E30.5
Technical Analysis
TrendBearish
RSI53.3
Support$71.00
Resistance$80.17
MA 20$75.58
MA 50$75.67
MA 200$104.14
MACDBullish
VolumeDecreasing
Fear & Greed Index95.66
Valuation
Fair Value$44.30
Target Price$96.00
Upside/Downside24.13%
GradeUndervalued
TypeValue
Dividend Yield2.83%
Risk Assessment
Beta0.58
Volatility37.79%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.